Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × Mass Spectrometry × Clear all

Sponsor

Conditions

Rectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Melanoma 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cardiotoxicity 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms, Male 1 Adenocarcinoma Of Esophagus 1

Interventions

pazopanib 5 Doxorubicin 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 romidepsin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Paclitaxel 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Dexrazoxane 1 Cyproheptadine 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡